CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for J Frontier Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

J Frontier Co Ltd
4F, KN Shibuya 3, 9-8, Sakuragaoka-cho
Phone: +81 364274662p:+81 364274662 SHIBUYA-KU, TKY  150-0031  Japan Ticker: 29342934
Business Summary
J Frontier Co Ltd is a Japan-based company mainly engaged in the electronic commerce sale business for healthcare-related products and pharmaceuticals, the provision of online medication guidance, drug delivery platform SOKUYAKU, as well as the Internet advertising agency business for healthcare-related services. The Company operates through three business segments. The Healthcare Sales segment is engaged in the planning and development of health foods and cosmetics represented by the 328 selection series of fermented hydrogen and mail-order sales. The Medical Care Sales segment is engaged in the operation of dispensing pharmacies, mail-order business of ethical drugs, as well as planning, development and mail-order sales of drugs such as Why Pure series and Chinese herbs. The Health Care Marketing segment is mainly engaged in advertising agency business related to health care products, sales promotion support for health care products, as well as wholesale of in-house products.
(Source: N-30D)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
2/29/20245/31/2023Yes----

Industries
SIC Code Description
5912 Drug stores and proprietary stores
5122 Drugs, drug proprietaries, and druggists' sundries
7375 Information retrieval services
7311 Advertising agencies
5499 Miscellaneous food stores

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Executive President, Representative Director AtsuhiroNakamura 43 3/1/2021 3/1/2021
Chief Operating Officer, Executive Officer, Chief Director of Health Care Sales Business, Director SatoshiKambe 54 8/1/2022 4/1/2022
Executive Officer, Chief Director of Corporate SumikoOkamoto 1/1/2023 9/1/2022
3 additional Officers and Directors records available in full report.

General Information
Number of Employees: 255 (As of 5/31/2023)
Outstanding Shares: 4,946,936 (As of 9/30/2024)
Shareholders: 1,918
Stock Exchange: TYO
Fax Number: +81 364275969


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024